首頁 > 市場調查報告書 > 醫療設備

眼科設備

市場調查報告書

商品編碼

1623447

全球無晶體眼市場規模（按類型、治療、最終用戶、地區、範圍和預測）

Global Aphakia Market Size By Type (Congenital Aphakia, Surgical Aphakia), By Treatment (Spectacles, Contact Lenses), By End User (Hospitals, Ophthalmic clinics), By Geographic Scope And Forecast

出版日期: 2024年09月25日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

無晶體眼的市場規模及預測

無晶體眼市場規模預計在 2024 年達到 18.3 億美元，到 2031 年將達到 43 億美元，在 2024-2031 年預測期內的複合年增長率為 11.3%。由於人口老化、醫療保健行業蓬勃發展以及對更好的眼疾治療的需求不斷增加，市場正在成長。本報告對全球無晶體眼市場進行了全面的評估。它對關鍵細分市場、趨勢、市場推動因素、阻礙因素、競爭格局以及在市場中發揮關鍵作用的因素進行了全面的分析。

定義全球無水晶體眼市場

無晶體眼是指眼內沒有水晶體，可能是因為水晶體已經由手術摘除，或因為出生時水晶體不存在。水晶體是眼睛內部的透明結構，有助於將光線聚焦到眼睛後部的視網膜上。如果沒有鏡片，視力就會嚴重受損，造成嚴重的視力傷害。無晶體症可能由多種原因引起，包括白內障手術、先天性水晶體缺失、外傷或感染。

可以透過手術摘除天然水晶體，並以人工水晶體取代。然而，在某些情況下，例如患有先天性無晶體症的人，無法使用人工水晶體，人們必須依靠矯正鏡片或其他裝置來改善視力。無晶體眼患者往往有嚴重的屈光不正，包括嚴重的近視、遠視和散光。

通常，醫生會建議使用矯正鏡片（例如眼鏡或隱形眼鏡）來改善視力。在某些情況下，可能會建議使用稱為無晶體眼的特殊隱形眼鏡。儘管無晶體眼對視力有嚴重影響，但許多人在矯正鏡片和其他設備的幫助下能夠過正常、富有成效的生活。對於無晶體眼患者，定期進行眼科檢查非常重要，以監測視力並確保矯正鏡片是最新的。

全球無晶體眼市場概況

無晶體眼市場是指提供與無水晶體眼治療相關的產品和服務的產業。該市場包括矯正鏡片、人工鏡片等產品，以及有助於改善無晶體眼患者視力的其他設備。無晶體眼治療市場的發展主要受到白內障手術日益普及的推動，白內障手術是無晶體眼最常見的原因。

隨著人口老化和白內障手術數量的增加，無晶體眼護理相關產品和服務的需求預計會增加。無晶體眼治療市場也受到先進技術和創新產品成長的推動。例如，新型人工水晶體（如人工水晶體（IOL））的開發改善了白內障手術的結果並為無晶體眼患者提供了新的選擇。

總體而言，由於對無晶體眼和相關疾病的治療方案的需求不斷增加，無晶體眼市場預計未來將繼續增長。技術上的創新和進步可能會推動市場向前發展，為無晶體眼患者的視力和生活品質改善提供新的選擇和機會。

市場吸引力

透過提供市場吸引力的影像，您可以獲得有關領先全球無晶體眼科市場的地區的資訊。我們涵蓋了推動指定區域產業成長的主要影響因素。

波特五力模型

波特五力框架為理解競爭對手的行為和每個產業參與者的策略定位提供了藍圖。波特五力模型可用於評估全球無水晶體眼市場的競爭格局、衡量特定細分市場的吸引力以及評估投資潛力。

Aphakia Market size was valued at USD 1.83 Billion in 2024 and is projected to reach USD 4.30 Billion by 2031, growing at a CAGR of 11.3% during the forecast period 2024-2031. The market is growing as a result of the aging population, the quickly growing healthcare industry, and the rising demand for better ocular disease treatment. The Global Aphakia Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors playing a substantial role in the market.

Global Aphakia Market Definition

Aphakia is a condition in which a person's eye is missing its natural lens, either because it was surgically removed or because it was never present at birth. The lens is the transparent structure inside the eye that helps to focus light onto the retina at the back of the eye. Without a lens, vision can be severely impaired, causing significant visual problems. Aphakia can result from various causes, including cataract surgery, congenital absence of the lens, trauma, or infection.

When the natural lens is removed surgically, an artificial lens can be implanted to replace it. However, in some cases, such as with congenital aphakia, an artificial lens may not be an option, and the person may need to rely on corrective lenses or other devices to improve their vision. People with aphakia often have significant refractive errors, such as high degrees of nearsightedness or farsightedness, and astigmatism.

Corrective lenses, such as glasses or contact lenses, are often prescribed to help improve vision. In some cases, a special type of contact lens called an aphakic lens may be recommended, which is designed to compensate for the lack of a natural lens. While vision can be significantly affected by aphakia, many people with the condition are able to lead normal, productive lives with the help of corrective lenses or other devices. Regular eye exams are important for people with aphakia to monitor their vision and ensure that their corrective lenses are up to date.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Aphakia Market Overview

The Aphakia Market refers to the industry that provides products and services related to the treatment of the condition known as aphakia, in which a person's natural lens is missing from their eye. The market includes products such as corrective lenses, artificial lenses, and other devices that can help improve vision in people with aphakia. The market for aphakia treatment is primarily driven by the increasing prevalence of cataract surgery, which is the most common cause of aphakia.

As the population ages and the number of cataract surgeries performed increases, the demand for products and services related to aphakia treatment is expected to grow. The market for aphakia treatment is also driven by the increasing availability of advanced technology and innovative products. For example, the development of new types of artificial lenses, such as intraocular lenses (IOLs), has improved the outcomes of cataract surgery and provided new options for people with aphakia.

Overall, the Aphakia Market is expected to continue to grow in the coming years as the demand for treatment options for aphakia and related conditions increases. New innovations and advancements in technology are likely to drive the market forward, providing new options and opportunities for people with aphakia to improve their vision and quality of life.

Market Attractiveness

The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Aphakia Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.

Porter's Five Forces

The image provided would further help to get information about Porter's five forces framework providing a blueprint for understanding the behavior of competitors and a player's strategic positioning in the respective industry. Porter's five forces model can be used to assess the competitive landscape in the Global Aphakia Market, gauge the attractiveness of a certain sector, and assess investment possibilities.

Global Aphakia Market Segmentation Analysis

The Global Aphakia Market is segmented on the basis of Type, Treatment, End User, and Geography.

Aphakia Market, By Type

Congenital Aphakia
Surgical Aphakia
Acquired Aphakia

Based on Type, the Aphakia Market is segmented into Congenital Aphakia, Surgical Aphakia, and Acquired Aphakia. Acquired Aphakia is a condition brought on by the absence of eye lenses. This disorder can affect people of any age, but it usually develops as a result of an accident, a procedure, or an illness such as osteogenesis imperfecta or glaucoma. Patients without a lens or its remnant are reported to have this kind of aphakia. Double vision and hazy vision are two of the signs of this type, while additional signs include cataract surgery, refractive surgery, etc.

Aphakia Market, By Treatment

Spectacles
Contact Lenses
Intraocular Lens Implantation
Refractive Surgery

Based on Treatment, the Aphakia Market is segmented into Spectacles, Contact Lenses, Intraocular Lens Implantation, and Refractive Surgery. When the natural lens of an eye gets foggy and cannot be corrected by regular glasses, aphakia is employed. This allows for a clean vision of objects that are different distances from the eyes. Once such treatment has been received, an aphakia patient will no longer require the use of any extra reading or near-vision lenses.

Aphakia Market, By End User

Hospitals
Ophthalmic clinics
Others

Based on End User, the Aphakia Market is segmented into Hospitals, Ophthalmic clinics, and Others.

Aphakia Market, By Geography

North America
Europe
Asia Pacific
Latin America
Middle East and Africa
On the basis of Regional Analysis, The Global Aphakia Market is classified into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Due to the rising prevalence of aphakia cases, advanced technology, the region's sizable diabetic population, and increased government funding for R&D, North America dominates the global aphakia industry. Because of its substantial and fast-expanding economy, sizable patient pool, rising frequency of ocular illnesses, and rapidly rising elderly population, Asia-Pacific is predicted to develop at a significant growth rate in the forecast period.

Key Players

The "Global Aphakia Market" study report will provide valuable insight with an emphasis on the Global market including some of the major key players such as
Johnson & Johnson Services, Inc., Ophtec BV, Novartis AG, Bausch Health, ZEISS International, Rayner Intraocular Lenses Limited, Aetna Inc., CooperVision, Menicon Co., Ltd., Labtician Ophthalmics, Inc., and Others.

Our market analysis contains a section exclusively devoted to such significant firms, where our experts provide a summary of each company's financial statements as well as product benchmarking and SWOT analysis. The competitive landscape section also includes the key development strategies, market share analysis, and market positioning analysis of the aforementioned competitors internationally.

Key Developments

In July 2022, Intraocular lenses (IOLs) from the Clareon(R)family have been made available in the United States, according to Alcon (SIX/NYSE: ALC), a leader in eye care around the world committed to enabling people to see brilliantly. The most cutting-edge IOL material from Alcon allows Clareon to produce consistently excellent visual results and long-lasting clarity. 1-7 When compared to the leading competitor IOLs, the glistening-free IOL material used in Clareon has some of the lowest levels of haze and subsurface nanoglistenings (SSNGs).
Ace Matrix Analysis
The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as
Active, Cutting Edge, Emerging, and Innovators.

1 INTRODUCTION OF GLOBAL APHAKIA MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL APHAKIA MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL APHAKIA MARKET, BY TYPE

5.1 Overview
5.2 Congenital Aphakia
5.3 Surgical Aphakia
5.4 Acquired Aphakia

6 GLOBAL APHAKIA MARKET, BY TREATMENT

6.1 Overview
6.2 Spectacles
6.3 Contact Lenses
6.4 Intraocular Lens Implantation
6.5 Refractive Surgery

7 GLOBAL APHAKIA MARKET, BY END USER

7.1 Overview
7.2 Hospitals
7.3 Ophthalmic Clinics
7.4 Others

8 GLOBAL APHAKIA MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East & Africa

9 GLOBAL APHAKIA MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies

10 COMPANY PROFILES

10.1 Johnson & Johnson Services, Inc.
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2 Ophtec BV
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
10.3 Novartis AG
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
10.4 Bausch Health
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
10.5 ZEISS International.
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
10.6 Rayner Intraocular Lenses Limited
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
10.7 Aetna Inc.
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
10.8 CooperVision
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
10.9 Menicon Co.Ltd.
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments
10.10 Labtician Ophthalmics, Inc.
- 10.10.1 Overview
- 10.10.2 Financial Performance
- 10.10.3 Product Outlook
- 10.10.4 Key Developments